Tristan R. Brown
Alternative energy, long/short equity, commodities, energy

Ceres Gets One More Shot At Its Sweet Sorghum Trials

Executive summary:

Ceres, a producer of genetically-engineered bioenergy feedstocks, has seen its price fall by 92% since its IPO due to a lack of global demand for lignocellulosic feedstocks and consecutive poor growing seasons in Brazil. The most recent hit to its share price came after the company reported highly variable sweet sorghum trial yields in its FQ3 2013 earnings report. While investors now appear to be concerned about the company's risk of default, it has enough cash to last it through another round of consumer trials. The stock is a highly speculative play on the results of these future trials.

Ceres (NASDAQ:CERE), a producer of genetically-engineered bioenergy feedstocks, has seen its share price fall by 64% in...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details